New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2013
10:13 EDTCGV, AMT, WYNN, R, DAL, ALKS, MKL, TCO, NWSA, CS, CCI, MO, SNCR, EVR, ACEOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ACE Ltd. (ACE) upgraded to Outperform from Market Perform at Wells Fargo... Alkermes (ALKS) upgraded to Overweight from Equal Weight at Morgan Stanley... CGG Veritas (CGV) upgraded to Neutral from Sell at Citigroup... Credit Suisse (CS) upgraded to Buy from Neutral at Nomura... Delta Air Lines (DAL) upgraded to Buy from Sell at Goldman... Evercore Partners (EVR) upgraded to Buy from Neutral at Goldman... News Corp. (NWSA) upgraded to Outperform from Market Perform at Bernstein... Ryder (R) upgraded to Buy from Neutral at Goldman... Synchronoss (SNCR) upgraded to Outperform from Market Perform at Wells Fargo... Taubman Centers (TCO) upgraded to Overweight from Equal Weight at Evercore... Wynn Resorts (WYNN) upgraded to Buy from Neutral at Lazard Capital... Altria Group (MO) upgraded to Buy from Hold at Stifel Nicolaus... Markel (MKL) upgraded to Neutral from Underperform at Macquarie... American Tower (AMT) upgraded to Overweight from Equal Weight at Evercore... Crown Castle (CCI) upgraded to Overweight from Equal Weight at Evercore.
News For ACE;ALKS;CGV;CS;DAL;EVR;NWSA;R;SNCR;TCO;WYNN;MO;MKL;AMT;CCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 21, 2015
16:01 EDTALKSAlkermes provides update on FDA review of ARISTADA
Alkermes announced that the U.S. FDA has advised Alkermes that it will not be able to complete its review of the New Drug Application for ARISTADA for the treatment of schizophrenia by the Prescription Drug User Fee Act action date of Aug. 22, 2015. The FDA indicated that this delay was expected to be brief, measured in terms of weeks, but could not confirm specific timing. The FDA also indicated that no additional data or information is required from Alkermes at this time. "We are confident in the ARISTADA program and our NDA submission, and we will work closely with the FDA as they complete their review," said Elliot Ehrich, M.D., Chief Medical Officer of Alkermes. "We look forward to bringing ARISTADA to market as a potential new treatment option to help address the significant unmet medical needs of patients living with schizophrenia."
12:04 EDTMOOn The Fly: Top stock stories at midday
Subscribe for More Information
11:01 EDTMOAltria Group increases quarterly dividend 8.7%
Subscribe for More Information
08:40 EDTCSCanadian Security Traders Association to hold a conference
Subscribe for More Information
07:17 EDTWYNNMacau developments negative, says Wells Fargo
Wells Fargo says that its checks on Macau for August indicate that the region's revenues are trending flat to down this month. According to Wells, in August the region's revenues are historically up 4% versus July. The firm adds that comments by Macau casino owner Galaxy suggest that the market has not yet bottomed. Wells believes that the market has not yet stabilized and remains neutral on Macau stocks, although it remains upbeat on their long-term outlook. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Melco Crown (MPEL) and Wynn Resorts (WYNN).
05:52 EDTDALDelta Air Lines implied volatility of 36 at lower end of index mean range
Subscribe for More Information
August 20, 2015
10:07 EDTACEHigh option volume stocks
High option volume stocks: HCBK BCOV MSG EMB MTH ACE PLKI OSK ACWI SOXX
06:07 EDTCSSamsung Bioepis picks Citi, Goldman as lead managers for IPO, Reuters says
Samsung Bioepis has selected Citigroup (C) and Goldman Sachs (GS) as the lead managers for its planned listening on Nasdaq next year, a source tells Reuters. Morgan Stanley (MS) and Credit Suisse (CS) will also take part in the listing for Samsung's (SSNLF) biosimilar drug development arm, the source says. Reference Link
August 18, 2015
20:00 EDTDALAirline stocks fall as companies face probes, labor issues, WSJ says
Subscribe for More Information
16:00 EDTDALOptions Update; August 18, 2015
Subscribe for More Information
07:13 EDTWYNNMacau GGR poised to sink 37% in August, says Bernstein
Subscribe for More Information
August 17, 2015
12:45 EDTCSLondon City Airport chooses Credit Suisse to advise possible sale, Reuters says
London City Airport's owners have selected Credit Suisse to advise them on a potential sale that could value the company at as much as $3.1B, Reuters reports, citing two sources close to the deal. Reference Link
10:10 EDTNWSAHigh option volume stocks
Subscribe for More Information
08:09 EDTACEACE Limited upgraded on Chubb acquisition at BMO Capital
Subscribe for More Information
06:24 EDTACEACE Limited upgraded to Outperform from Market Perform at BMO Capital
August 16, 2015
18:20 EDTDALFAA working with airlines to restore operations after August 15 cancellations
Subscribe for More Information
August 14, 2015
16:44 EDTDALThird Point gives quarterly update on stakes
NEW STAKES: Baxter (BAX), T-Mobile (TMUS), Sealed Air (SEE), Devon (DVN), and Perrigo (PRGO). INCREASED STAKES: SunEdison (SUNE), Dow Chemical (DOW), Mohawk (MHK), Yum! Brands (YUM), and IAC/InterActiveCorp (IACI). DECREASED STAKES: Ally Financial (ALLY), Amgen (AMGN), Sensata (ST), Masco (MAS), and Delta (DAL). LIQUIDATED STAKES: Dollar General (DG), McKesson (MCK), Edgewell Personal Care (EPC), Maxim (MXIM), and FleetCor (FLT).
10:07 EDTDALDelta Air Lines management to meet with Sterne Agee CRT
Meeting to be held in Atlanta on August 19 hosted by Sterne Agee CRT.
06:01 EDTDALDelta, Virtgin Australia Trans-Pacific alliance reauthorized by ACCC
Subscribe for More Information
06:01 EDTDALDelta Air Lines implied volatility of 31 at lower end of index mean range
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use